What are the brand names of Quinidine (quinidine)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Brand Names of Quinidine

Quinidine is available as quinidine sulfate and quinidine gluconate, with brand names including Quinidex, Quinora, Quiniday, and Quinaglute Dura-Tabs.

Available Formulations

Quinidine is available in two primary salt forms:

  1. Quinidine Sulfate:

    • Tablets: 200 mg (equivalent to 166 mg quinidine base) and 300 mg (equivalent to 249 mg quinidine base) 1
    • Brand names:
      • Quinidex Extentabs (600 mg twice daily extended-release formulation) 2
      • Quinora (300 mg four times daily) 2
      • Quiniday (1200 mg once daily extended-release formulation) 2
  2. Quinidine Gluconate:

    • Brand name:
      • Quinaglute Dura-Tabs (648 mg twice daily) 2

Clinical Context

Quinidine is classified as a Class IA antiarrhythmic drug according to the Vaughan Williams classification 3. It has been used for:

  • Management of atrial fibrillation
  • Treatment of ventricular arrhythmias
  • Treatment of severe Plasmodium falciparum malaria (as quinidine gluconate) 3

Formulation Differences

The different formulations offer various dosing schedules:

  • Immediate-release formulations (e.g., Quinora): Require more frequent dosing (four times daily)
  • Extended-release formulations (e.g., Quinidex Extentabs): Allow twice-daily dosing
  • Long-acting formulations (e.g., Quiniday): Allow once-daily dosing

Important Considerations

Quinidine is used less frequently than other antiarrhythmic agents due to:

  • Perception of lower efficacy compared to newer agents 3
  • Higher frequency of side effects, including QT-interval prolongation that may lead to torsades de pointes 3
  • Risk of hypotension and acceleration of ventricular response to atrial fibrillation on a vagolytic basis during initiation of therapy 3

Despite these concerns, quinidine has seen renewed interest in specific clinical scenarios, including:

  • Treatment of idiopathic ventricular fibrillation
  • Management of Brugada syndrome
  • Treatment of Short QT syndrome 4

When used for malaria treatment, quinidine gluconate is administered intravenously with careful cardiac monitoring due to potential cardiotoxicity 3.

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.